Kevin F. McLaughlin, SVP, CFO and Treasurer at ACCELERON PHARMA INC (XLRN), sold 648 shares at $48.02 ($31K) on 2019-04-02, disclosed to the SEC on 2019-04-04.
Scheduled sale ($31k) by SVP, CFO and Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VCEL | SELL | 2026-02-13 | $243K | — | Filing → |
| IVVD | BUY | 2025-11-20 | $125K | — | Filing → |
| VCEL | SELL | 2025-11-12 | $270K | — | Filing → |